enviracor J-5 100 mL (20 Doses)

For use in healthy dairy cattle, this product aids in the control of clinical signs associated with E. coli mastitis and shows a significant reduction in shedding E. coli—minimizing the spread of the disease. The three-dose regimen helps stimulate the immune system for optimum response to help fight clinical E. coli mastitis. For effective mastitis control, use with high-quality milking practices, sanitation and nutrition. 60 day slaughter withhold. Enviracor J5 is recommended for use in healthy dairy cattle as an aid in the control of clinical signs associated with E. coli mastitis. For effective mastitis control, this product should be used in conjunction with acceptable good management practices.
Shake well before using. Use entire contents when first opened. Three doses are required. Administer 5 ml dose subcutaneously in the neck. Vaccinate cows or heifers at 7 and 8 months gestation followed by a third dose within 2 weeks post-partum (after calving).

Directions: Shake well. Three doses are required. Administer each 5-mL dose subcutaneously, one hand-width cranial to the shoulder. Vaccinate cows or heifers at 7 and 8 months of gestation followed by the third dose within two weeks postpartum.

Mastitis caused by Escherichia coli (E. coli), and environmental pathogen, can be detrimental to dairy operations. It causes fever, abnormal milk, excessive udder edema, dehydration, dramatic drops in milk production and in severe cases death. Quarters infected often are damaged so damaged that they do not fully recover in production. Vaccination with J-5 lessens or prevents these clinical symptoms. This can have a significant economic impact on a herd.

enviracor J-5 - 100 mL (20 Doses) Highlights:

• SKU: 14428
• Manufacturer: Zoetis
• Available in 20 dose or 50 dose.
• Safe to Use in Pregnant Animals.
• Contains the J-5 strain of Escherichia coli.
• Store at 35 to 45 ˚F (2 to 7 ˚C). Do not freeze.
• Do not vaccinate within 60 days of slaughter.
• Local swelling may occur and persist at the injection site.
• Anaphylactic reactions may occur, epinephrine should be administered immediately.
• The duration of E. coli mastitis is significantly shorter in vaccinated cows than non-vaccinated cows, which means less loss of production and shorter recovery.
• Cows that were vaccinated experienced a significant reduction in shedding E. coli which means they are less likely to pass it on to other animals.